Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05852600 · ClinicalTrials.gov registry record · NA
Parent-focused Intervention to Reduce HIV Risk in Gay and Bisexual Adolescents
A NA study of HIV and Sexual Health, sponsored by George Washington University.
- Active
- Registry status
- NA
- Development phase
- 393
- Enrollment target
- 1
- Study location
NCT05852600: Active NA study of HIV and Sexual Health, sponsored by George Washington University.
NCT05852600 is a NA study of HIV and Sexual Health that is active but no longer recruiting, run by George Washington University. The registered enrollment target is 393 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05852600, a NA study of HIV and Sexual Health, is active but no longer recruiting, sponsored by George Washington University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 393 participants
- Enrollment target
- 1
- Study location
Study Summary
Gay and bisexual youth make up 80% of all new HIV infections among adolescents ages 14-19 in the United States, yet interventions to improve sexual health outcomes in these youth are extremely limited. Our team has developed an intervention -- Parents and Adolescents Talking about Healthy Sexuality (PATHS) -- to reduce HIV risk for gay and bisexual youth by working with their parents to improve the ways parents communicate with their sons about sexual health. The intervention is all completed by parents online and takes 45-60 minutes to complete. The goal of this study is to test whether PATHS helps improve sexual health among gay and bisexual male teens ages 14-19. To do this 350 parent-adolescent dyads will be recruited online (50% of those dyads will be racial/ethnic minority). Parents will be randomized to receive either PATHS or a control (a film designed to general support parents of gay/bisexual youth). Parents and sons will then complete surveys every 3 months over a 1-year period. Families assigned to PATHS will be compared to families assigned to the film 6 months after the intervention. Then the families originally given the control film will receive PATHS, and all dyads will be followed for another 6 months. This allows us to test the effects of PATHS in the control arm (by comparing families' experiences in the 6 months before they received the PATHS to their experiences over the next 6 months). It also allows us to test whether families who originally received PATHS will continue to benefit 9 and 12-months after the intervention. To assess sexual health, adolescents will complete self-report measures of their comfort using condoms, their access to condoms, their knowledge of the correct way to use a condom, their intentions to use condoms, their awareness of pre-exposure prophylaxis as an HIV prevention method, and their attitudes toward PrEP. If they are sexually active, they will also report about their history of condom use during sex. Adolescents
Primary Outcome
15-item scale assessing youth's confidence in their ability to correctly use and acquire condoms.
Conditions Studied
Interventions
- BEHAVIORAL Parents and Adolescents Talking about Healthy Sexuality (PATHS)
- BEHAVIORAL Lead with Love (LWL)
Study Locations (1)
District of Columbia
- George Washington University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 393 participants |
| Start Date | 2023-04-24 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
What the registry record for NCT05852600 still lists
NCT05852600 is an interventional study that assigns participants to a tested intervention. The registered 393 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (10% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Parents and Adolescents Talking about Healthy Sexuality (PATHS) is the first listed.
NCT05852600 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05852600 about?
NCT05852600 is a clinical study titled "Parent-focused Intervention to Reduce HIV Risk in Gay and Bisexual Adolescents". Gay and bisexual youth make up 80% of all new HIV infections among adolescents ages 14-19 in the United States, yet interventions to improve sexual health outcomes in these youth are extremely limited. Our team has developed an intervention -- Parents and Adolescents Talking about Healthy Sexuality ...
What is the current status of trial NCT05852600?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 393 participants. The study started on 2023-04-24. Estimated completion is 2026-11-01.
What conditions does trial NCT05852600 study?
This clinical trial studies the following conditions: HIV, Sexual Health.
What interventions are being tested in trial NCT05852600?
The interventions under investigation include: Parents and Adolescents Talking about Healthy Sexuality (PATHS) (BEHAVIORAL), Lead with Love (LWL) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05852600?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05852600 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05852600's enrollment target sits among peer trials
393 49th of 303 higher than 255 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05640999 · 393 participants · Phase 2
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- NCT06613698 · 393 participants · Phase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease
- NCT06657924 · 394 participants · Phase 2
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
- NCT07225660 · 394 participants · NA
Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI